DE60205937T2 - Homogen beschichtete vorrichtung mit osteoinduktiven und osteokonduktiven eigenschaften - Google Patents

Homogen beschichtete vorrichtung mit osteoinduktiven und osteokonduktiven eigenschaften Download PDF

Info

Publication number
DE60205937T2
DE60205937T2 DE60205937T DE60205937T DE60205937T2 DE 60205937 T2 DE60205937 T2 DE 60205937T2 DE 60205937 T DE60205937 T DE 60205937T DE 60205937 T DE60205937 T DE 60205937T DE 60205937 T2 DE60205937 T2 DE 60205937T2
Authority
DE
Germany
Prior art keywords
osteoinductive
relates
osteoconductive properties
homogen
coated device
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60205937T
Other languages
English (en)
Other versions
DE60205937D1 (de
DE60205937T3 (de
Inventor
Ulrich Kohnert
Sylke Poehling
Klaus Hellerbrand
Peter Happersberger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bionet Pharma GmbH
Original Assignee
Scil Technology GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8179288&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60205937(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scil Technology GmbH filed Critical Scil Technology GmbH
Publication of DE60205937D1 publication Critical patent/DE60205937D1/de
Publication of DE60205937T2 publication Critical patent/DE60205937T2/de
Application granted granted Critical
Publication of DE60205937T3 publication Critical patent/DE60205937T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/02—Surgical adhesives or cements; Adhesives for colostomy devices containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/108—Specific proteins or polypeptides not covered by groups A61L24/102 - A61L24/106
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/12—Phosphorus-containing materials, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Inorganic Chemistry (AREA)
  • Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glass Compositions (AREA)
  • Apparatuses And Processes For Manufacturing Resistors (AREA)
  • Permanent Magnet Type Synchronous Machine (AREA)
  • Dental Preparations (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Prostheses (AREA)
DE60205937.2T 2001-11-19 2002-03-27 Methode zur Herstellung einer homogen beschichtete Vorrichtung mit osteoinduktiven und osteokonduktiven Eigenschaft Expired - Lifetime DE60205937T3 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP01127573 2001-11-19
EP01127573 2001-11-19
PCT/EP2002/003463 WO2003043673A1 (en) 2001-11-19 2002-03-27 Device having osteoinductive and osteoconductive properties
EP02803343.9A EP1448246B2 (de) 2001-11-19 2002-03-27 Methode zur herstellung einer homogen beschichtete vorrichtung mit osteoinduktiven und osteokonduktiven eigenschaften

Publications (3)

Publication Number Publication Date
DE60205937D1 DE60205937D1 (de) 2005-10-06
DE60205937T2 true DE60205937T2 (de) 2006-06-14
DE60205937T3 DE60205937T3 (de) 2016-01-21

Family

ID=8179288

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60205937.2T Expired - Lifetime DE60205937T3 (de) 2001-11-19 2002-03-27 Methode zur Herstellung einer homogen beschichtete Vorrichtung mit osteoinduktiven und osteokonduktiven Eigenschaft

Country Status (16)

Country Link
US (2) US8546334B2 (de)
EP (1) EP1448246B2 (de)
JP (2) JP4473576B2 (de)
CN (1) CN100425285C (de)
AT (1) ATE303169T1 (de)
AU (1) AU2002308204B9 (de)
BR (1) BR0214275A (de)
CA (1) CA2466947C (de)
CY (1) CY1105664T1 (de)
DE (1) DE60205937T3 (de)
DK (1) DK1448246T4 (de)
ES (1) ES2247423T5 (de)
HK (1) HK1071315A1 (de)
PT (1) PT1448246E (de)
SI (1) SI1448246T2 (de)
WO (1) WO2003043673A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1462126A1 (de) * 2003-03-28 2004-09-29 BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH Verbesserte osteoinduktive Materialien
JP4944010B2 (ja) * 2004-03-10 2012-05-30 サイル テクノロジー ゲーエムベーハー コーティングされたインプラント、その製造および使用
EP1753396A2 (de) * 2004-06-09 2007-02-21 Scil Technology GmbH Verbundmaterial zur verwendung als proteinträger
EP1604694A1 (de) * 2004-06-09 2005-12-14 Scil Technology GmbH Kompositvorrichtung mit osteoinduktiven und osteokonduktiven Eigenschaften
EP1604693A1 (de) 2004-06-09 2005-12-14 Scil Technology GmbH In-situ hergestelltes Gerüst, dessen Herstellungsverfahren und dessen Verwendung
US20060286171A1 (en) * 2005-06-17 2006-12-21 Tianhong Zhou Bone morphogenetic protein formulations
AU2006326271B2 (en) * 2005-12-14 2011-02-24 Scil Technology Gmbh A moldable biomaterial for bone regeneration
US20070299520A1 (en) * 2006-06-26 2007-12-27 Warsaw Orthopedic, Inc. Surface treatment of implantable devices
AU2007234612B2 (en) * 2006-12-14 2013-06-27 Johnson & Johnson Regenerative Therapeutics, Llc Protein stabilization formulations
DE102006060958A1 (de) 2006-12-20 2008-06-26 Jennissen, Herbert P., Prof. Dr. Verfahren zur Herstellung einer Polymermatrix, daraus bestehende Implantate sowie deren Verwendung
US20080221681A1 (en) * 2007-03-09 2008-09-11 Warsaw Orthopedic, Inc. Methods for Improving Fatigue Performance of Implants With Osteointegrating Coatings
US7678764B2 (en) 2007-06-29 2010-03-16 Johnson & Johnson Regenerative Therapeutics, Llc Protein formulations for use at elevated temperatures
JP5323832B2 (ja) * 2007-08-07 2013-10-23 アドバンスト・テクノロジーズ・アンド・リジェネレイティブ・メディスン・エルエルシー 酸性水溶液中にｇｄｆ−５を含むタンパク質製剤
US20090061002A1 (en) * 2007-09-05 2009-03-05 Venbrocks Rudolf A Calcium phospate based delivery of growth and differentiation factors to compromised bone
DE102007051914A1 (de) * 2007-10-29 2009-05-07 Herbert Prof. Dr. Jennissen Verfahren zur Herstellung von mit Wachstumsfaktoren beladenen Partikeln sowie die so erhaltenen Partikel
CA2720845A1 (en) * 2008-04-14 2009-10-22 Advanced Technologies And Regenerative Medicine, Llc Liquid buffered gdf-5 formulations
US20110059149A1 (en) * 2008-06-16 2011-03-10 Little Marisa A Process for depositing calcium phosphate therapeutic coatings with different release rates and a prosthesis coated via the process
CN102448505B (zh) * 2009-05-28 2015-04-15 埃得生物公司 多层蛋白质膜、制造方法以及使用该膜的药物递送装置和生物医学植入物
AU2011284657B2 (en) * 2010-07-30 2013-11-14 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh Drug delivery devices and growth factor formulations for accelerated wound healing
WO2012093939A1 (en) 2011-01-05 2012-07-12 Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patiëntenzorg Particles comprising calcium phosphate and use thereof
EP3682931A1 (de) * 2019-01-21 2020-07-22 Universitätsklinikum Hamburg-Eppendorf Thorakaler katheter

Family Cites Families (139)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3329128A1 (de) 1983-08-11 1985-02-28 Bayer Ag, 5090 Leverkusen 3-cycloalkyl-1-(1,3-dioxan-5-yl)-2-(1,2,4-triazol-1-yl)-propan-1-one und -propan-1-ole
US4596574A (en) * 1984-05-14 1986-06-24 The Regents Of The University Of California Biodegradable porous ceramic delivery system for bone morphogenetic protein
ZA874681B (en) 1986-07-01 1988-04-27 Genetics Inst Novel osteoinductive factors
US5187076A (en) 1986-07-01 1993-02-16 Genetics Institute, Inc. DNA sequences encoding BMP-6 proteins
US5108922A (en) 1986-07-01 1992-04-28 Genetics Institute, Inc. DNA sequences encoding BMP-1 products
US6150328A (en) 1986-07-01 2000-11-21 Genetics Institute, Inc. BMP products
US5631142A (en) 1986-07-01 1997-05-20 Genetics Institute, Inc. Compositions comprising bone morphogenetic protein-2 (BMP-2)
IL83003A (en) 1986-07-01 1995-07-31 Genetics Inst Factors that soak bone formation
US5013649A (en) 1986-07-01 1991-05-07 Genetics Institute, Inc. DNA sequences encoding osteoinductive products
US6432919B1 (en) 1986-07-01 2002-08-13 Genetics Institute, Inc. Bone morphogenetic protein-3 and compositions
US5939388A (en) 1986-07-01 1999-08-17 Rosen; Vicki A. Methods of administering BMP-5 compositions
US4877864A (en) 1987-03-26 1989-10-31 Genetics Institute, Inc. Osteoinductive factors
US5459047A (en) 1986-07-01 1995-10-17 Genetics Institute, Inc. BMP-6 proteins
WO1990011366A1 (en) 1989-03-28 1990-10-04 Genetics Institute, Inc. Osteoinductive compositions
US5543394A (en) 1986-07-01 1996-08-06 Genetics Institute, Inc. Bone morphogenetic protein 5(BMP-5) compositions
US5366875A (en) 1986-07-01 1994-11-22 Genetics Institute, Inc. Methods for producing BMP-7 proteins
US5106748A (en) 1986-07-01 1992-04-21 Genetics Institute, Inc. Dna sequences encoding 5 proteins
US5354557A (en) * 1988-04-08 1994-10-11 Stryker Corporation Osteogenic devices
DE01201546T1 (de) 1988-04-08 2004-07-08 Stryker Corp., Kalamazoo Osteogene Einrichtungen
US5344654A (en) * 1988-04-08 1994-09-06 Stryker Corporation Prosthetic devices having enhanced osteogenic properties
US4975526A (en) 1989-02-23 1990-12-04 Creative Biomolecules, Inc. Bone collagen matrix for zenogenic implants
US5324819A (en) * 1988-04-08 1994-06-28 Stryker Corporation Osteogenic proteins
US5670336A (en) 1988-04-08 1997-09-23 Stryker Corporation Method for recombinant production of osteogenic protein
US5266683A (en) * 1988-04-08 1993-11-30 Stryker Corporation Osteogenic proteins
US5258494A (en) 1988-04-08 1993-11-02 Stryker Corporation Osteogenic proteins
US5162114A (en) 1989-02-23 1992-11-10 Stryker Corporation Bone collagen matrix for xenogenic implants
US6586388B2 (en) * 1988-04-08 2003-07-01 Stryker Corporation Method of using recombinant osteogenic protein to repair bone or cartilage defects
US5011691A (en) * 1988-08-15 1991-04-30 Stryker Corporation Osteogenic devices
US5258029A (en) 1988-09-29 1993-11-02 Collagen Corporation Method for improving implant fixation
US5207710A (en) † 1988-09-29 1993-05-04 Collagen Corporation Method for improving implant fixation
US5108436A (en) 1988-09-29 1992-04-28 Collagen Corporation Implant fixation
US5422340A (en) * 1989-09-01 1995-06-06 Ammann; Arthur J. TGF-βformulation for inducing bone growth
US5158934A (en) 1989-09-01 1992-10-27 Genentech, Inc. Method of inducing bone growth using TGF-β
ES2118723T3 (es) 1989-10-17 1998-10-01 Stryker Corp Dispositivos osteogenicos.
DK27390D0 (da) 1990-02-02 1990-02-02 Troels Torp Andreassen Fremgangsmaade og apparat til administration af biologisk aktive stoffer
ATE168719T1 (de) 1990-10-18 1998-08-15 Stryker Corp Osteogene peptide
DK0575555T3 (da) 1991-03-11 2001-11-05 Curis Inc Proteininduceret morfogenese
US5652118A (en) 1991-03-11 1997-07-29 Creative Biomolecules, Inc. Nucleic acid encoding a novel morphogenic protein, OP-3
US6723698B2 (en) 1991-03-11 2004-04-20 Curis, Inc. Methods and compositions for the treatment of motor neuron injury and neuropathy
US5739107A (en) 1991-03-11 1998-04-14 Creative Biomolecules, Inc. Morphogen treatment of gastrointestinal ulcers
US6495513B1 (en) 1991-03-11 2002-12-17 Curis, Inc. Morphogen-enhanced survival and repair of neural cells
US6211146B1 (en) 1991-03-11 2001-04-03 Curis, Inc. 60A protein-induced morphogenesis
CA2104678C (en) 1991-03-11 2002-05-14 Charles M. Cohen Protein-induced morphogenesis
US5656593A (en) 1991-03-11 1997-08-12 Creative Biomolecules, Inc. Morphogen induced periodontal tissue regeneration
US6395883B1 (en) 1991-03-11 2002-05-28 Curis, Inc. Soluble morphogenic protein complex compositions of matter
US5650276A (en) 1991-03-11 1997-07-22 Creative Biomolecules, Inc. Morphogenic protein screening method
US6194376B1 (en) 1991-03-11 2001-02-27 Creative Biomolecules, Inc. Method for modulating inflammatory response comprising administering morphogen
US6800603B2 (en) 1991-03-11 2004-10-05 Curis, Inc. Morphogen-induced neural cell adhesion
US5652337A (en) 1991-03-11 1997-07-29 Creative Biomolecules, Inc. OP-3-induced morphogenesis
US6506729B1 (en) 1991-03-11 2003-01-14 Curis, Inc. Methods and compositions for the treatment and prevention of Parkinson's disease
US6077823A (en) 1991-03-11 2000-06-20 Creative Biomolecules, Inc. Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury
US5707810A (en) 1991-03-11 1998-01-13 Creative Biomolecules, Inc. Method of diagnosing renal tissue damage or disease
US5674844A (en) 1991-03-11 1997-10-07 Creative Biomolecules, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
US6090776A (en) 1991-03-11 2000-07-18 Creative Bio Molecules, Inc. Morphogen treatment of organ implants
US5849686A (en) 1991-03-11 1998-12-15 Creative Biomolecules, Inc. Morphogen-induced liver regeneration
US5972884A (en) 1991-03-11 1999-10-26 Creative Biomolecules, Inc. Morphogen treatment of gastrointestinal ulcers
US5563124A (en) 1991-04-22 1996-10-08 Intermedics Orthopedics/ Denver, Inc. Osteogenic product and process
US5290763A (en) 1991-04-22 1994-03-01 Intermedics Orthopedics/Denver, Inc. Osteoinductive protein mixtures and purification processes
US5177406A (en) 1991-04-29 1993-01-05 General Motors Corporation Active matrix vacuum fluorescent display with compensation for variable phosphor efficiency
DE4121043A1 (de) * 1991-06-26 1993-01-07 Merck Patent Gmbh Knochenersatzmaterial mit fgf
EP0523926A3 (en) 1991-07-15 1993-12-01 Smith & Nephew Richards Inc Prosthetic implants with bioabsorbable coating
EP0601106B2 (de) 1991-08-30 2003-11-05 Curis, Inc. Morphogen-induzierte Modulation von entzündlichen Antworten
US6022853A (en) 1991-08-30 2000-02-08 Creative Biomolecules, Inc. Morphogen-enriched dietary composition
WO1993005751A2 (en) 1991-08-30 1993-04-01 Creative Biomolecules, Inc. Osteogenic proteins in the treatment of bone deseases
SE469653B (sv) 1992-01-13 1993-08-16 Lucocer Ab Poroest implantat
US6120760A (en) 1992-02-12 2000-09-19 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Growth/differentiation factors of the TGF-β family
ATE188996T1 (de) 1992-02-12 2000-02-15 Bioph Biotech Entw Pharm Gmbh Dna-sequenzen kodierend für neuartige wachstums- /differentierungsfaktoren
US6013853A (en) 1992-02-14 2000-01-11 The University Of Texas System Continuous release polymeric implant carrier
US5876452A (en) 1992-02-14 1999-03-02 Board Of Regents, University Of Texas System Biodegradable implant
DE69307299T2 (de) 1992-02-14 1997-04-30 Univ Texas Mehrphasiges, biologisch abbaubares implantat/träger und verfahren zu seiner herstellung
US6071695A (en) * 1992-02-21 2000-06-06 Creative Biomolecules, Inc. Methods and products for identification of modulators of osteogenic protein-1 gene expression
US5610021A (en) * 1992-02-21 1997-03-11 Creative Biomolecules, Inc. Compositions and methods for identification and use of soluble complex forms of osteogenic proteins
US5397235A (en) 1993-07-02 1995-03-14 Dental Marketing Specialists, Inc. Method for installation of dental implant
EP0690871A4 (de) 1993-01-12 1999-10-20 Univ Johns Hopkins Med Wachstums-differenzierungsfaktor-5
CA2151486A1 (en) 1993-01-12 1994-07-21 Arthur J. Ammann Tgf-beta formulation for inducing bone growth
US5385887A (en) * 1993-09-10 1995-01-31 Genetics Institute, Inc. Formulations for delivery of osteogenic proteins
US6027919A (en) 1993-12-07 2000-02-22 Genetics Institute, Inc. BMP-12 and BMP-13 proteins and DNA encoding them
AU689184B2 (en) 1993-12-07 1998-03-26 Genetics Institute, Llc BMP-12, BMP-13 and tendon-inducing compositions thereof
US6013517A (en) 1994-05-09 2000-01-11 Chiron Corporation Crossless retroviral vectors
US5681746A (en) 1994-12-30 1997-10-28 Chiron Viagene, Inc. Retroviral delivery of full length factor VIII
ES2153564T3 (es) 1995-03-01 2001-03-01 Stryker Corp Regeneracion de la dentina inducida por un morfogeno.
US5782919A (en) * 1995-03-27 1998-07-21 Sdgi Holdings, Inc. Interbody fusion device and method for restoration of normal spinal anatomy
US5635372A (en) 1995-05-18 1997-06-03 Genetics Institute, Inc. BMP-15 compositions
US6117456A (en) 1995-05-19 2000-09-12 Etex Corporation Methods and products related to the physical conversion of reactive amorphous calcium phosphate
US6541037B1 (en) 1995-05-19 2003-04-01 Etex Corporation Delivery vehicle
US6287341B1 (en) 1995-05-19 2001-09-11 Etex Corporation Orthopedic and dental ceramic implants
US8333996B2 (en) 1995-05-19 2012-12-18 Etex Corporation Calcium phosphate delivery vehicle and adjuvant
US6027742A (en) 1995-05-19 2000-02-22 Etex Corporation Bioresorbable ceramic composites
US5676976A (en) 1995-05-19 1997-10-14 Etex Corporation Synthesis of reactive amorphous calcium phosphates
US6132463A (en) 1995-05-19 2000-10-17 Etex Corporation Cell seeding of ceramic compositions
EP1364656B1 (de) 1995-06-05 2013-11-20 Genetics Institute, LLC Verwendung von Knochenmorphogeneseproteinen zur Heilung und Reparatur von Bindegewebebefestigung
EP0883410B1 (de) * 1996-02-29 2004-08-18 Bioactive Bone Substitute OY, AB Osteogene vorrichtungen und methode zur herstellung derselben
EP0806211B1 (de) 1996-05-10 2002-10-23 IsoTis N.V. Implantatwerkstoff und Verfahren zu seiner Herstellung
ES2185861T3 (es) 1996-05-10 2003-05-01 Isotis Nv Material para implantes y procedimiento de fabricacion del mismo.
EP0806212B1 (de) 1996-05-10 2003-04-02 IsoTis N.V. Vorrichtung zur Aufnahme und Freigabe von biologisch aktiven Substanzen
US6143948A (en) 1996-05-10 2000-11-07 Isotis B.V. Device for incorporation and release of biologically active agents
US6953594B2 (en) 1996-10-10 2005-10-11 Etex Corporation Method of preparing a poorly crystalline calcium phosphate and methods of its use
DK0936929T3 (da) 1996-10-16 2004-11-08 Etex Corp Fremgangsmåde til fremstilling af svag krystallinsk calciumphosphat samt fremgangsmåder til dens anvendelse
DE19647853A1 (de) 1996-11-19 1998-05-20 Bioph Biotech Entw Pharm Gmbh Verbindungen mit verbesserter knorpel- und/oder knocheninduzierender Aktivität
US20020082224A1 (en) 1997-01-14 2002-06-27 Douglas J. Jolly Non-immunogenic prodrugs and selectable markers for use in gene therapy
KR100548107B1 (ko) 1997-01-30 2006-02-02 바이오팜 게젤샤프트 쭈어 바이오테히놀로지셴 엔트비클룽 폰 파르마카 엠베하 뼈 유도 인자 인간 ｍｐ52 동결 건조 조성물
WO1998034655A1 (en) 1997-02-07 1998-08-13 Stryker Corporation Matrix-free osteogenic devices, implants and methods of use thereof
US20020098222A1 (en) 1997-03-13 2002-07-25 John F. Wironen Bone paste
US20030032586A1 (en) * 1997-05-15 2003-02-13 David C. Rueger Compositions for morphogen-induced osteogenesis
WO1999011202A1 (en) 1997-09-05 1999-03-11 Icet, Inc. Biomimetic calcium phosphate implant coatings and methods for making the same
WO1999015641A1 (en) 1997-09-24 1999-04-01 The Regents Of The University Of California Non-primate lentiviral vectors and packaging systems
WO1999036511A2 (en) 1998-01-16 1999-07-22 Chiron Corporation Feline immunodeficiency virus gene therapy vectors
US20020048805A1 (en) 1998-01-16 2002-04-25 Julie C. Johnston Feline immunodeficiency virus gene therapy vectors
US6365150B1 (en) 1998-05-13 2002-04-02 Genetix Pharmaceuticals, Inc. Lentiviral packaging cells
US6261322B1 (en) 1998-05-14 2001-07-17 Hayes Medical, Inc. Implant with composite coating
KR100298178B1 (ko) 1998-06-29 2001-08-07 박종섭 이미지센서의포토다이오드
US6328765B1 (en) 1998-12-03 2001-12-11 Gore Enterprise Holdings, Inc. Methods and articles for regenerating living tissue
US6423544B1 (en) 1998-12-31 2002-07-23 Chiron Corporation Compositions and methods for producing recombinant virions
ATE253385T1 (de) 1999-02-04 2003-11-15 Sdgi Holdings Inc Hochmineralisierte osteogene schwammzusammensetzungen und ihre verwendung
DE60020526T2 (de) 1999-02-04 2006-05-11 SDGI Holdings, Inc., Wilmington Osteogene pastenzusammensetzungen und ihre verwendung
US6730297B1 (en) 1999-05-28 2004-05-04 Chiron Corporation Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders
SE515695C2 (sv) 1999-05-31 2001-09-24 Nobel Biocare Ab Implantat med beläggning av bentillväxtstimulerande substans för applicering i ben och förfarande vid sådant implantat
SE514202C2 (sv) 1999-05-31 2001-01-22 Nobel Biocare Ab På implantat till ben- eller vävnadsstruktur anordnat skikt samt sådant implantat och förfarande för applicering av skiktet
SE514323C2 (sv) 1999-05-31 2001-02-12 Nobel Biocare Ab Implantat samt förfarande och användning vid implantat
AU6499700A (en) * 1999-07-28 2001-02-19 Regeneration Technologies, Inc. Reduced antigenicity tissue (rat) implants
US6696410B1 (en) * 1999-09-27 2004-02-24 Stryker Corporation Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptors
AU774427B2 (en) 1999-10-15 2004-06-24 Fidia Advanced Biopolymers S.R.L. Formulations of hyaluronic acid for delivery of osteogenic proteins
AU1086601A (en) 1999-10-15 2001-04-30 Genetics Institute Inc. Formulations for delivery of osteogenic proteins
DE19950386A1 (de) 1999-10-19 2001-05-10 Miladin Lazarov Biokompatibler Gegenstand
DE60100433T2 (de) † 2000-02-04 2004-04-15 Chienna B.V. Proteinbeschichtung
US20020022885A1 (en) * 2000-05-19 2002-02-21 Takahiro Ochi Biomaterial
US20020037281A1 (en) 2000-05-26 2002-03-28 Davidson Beverly L. Methods of transducing neural cells using lentivirus vectors
US6533821B1 (en) 2000-06-22 2003-03-18 Thomas Lally Bio-adhesive composition, method for adhering objects to bone
US7419829B2 (en) 2000-10-06 2008-09-02 Oxford Biomedica (Uk) Limited Vector system
WO2002042482A2 (en) 2000-11-27 2002-05-30 Chiron Corporation Functional lentiviral vector from an mlv-based backbone
US20020082679A1 (en) * 2000-12-22 2002-06-27 Avantec Vascular Corporation Delivery or therapeutic capable agents
WO2002054088A2 (en) 2001-01-05 2002-07-11 Duke University Contrast enhancement agent for magnetic resonance imaging
US20030049328A1 (en) * 2001-03-02 2003-03-13 Dalal Paresh S. Porous beta-tricalcium phosphate granules and methods for producing same
US6949251B2 (en) 2001-03-02 2005-09-27 Stryker Corporation Porous β-tricalcium phosphate granules for regeneration of bone tissue
EP1492475B1 (de) 2001-04-16 2011-12-21 Wright Medical Technology, Inc. Dichte/poröse strukturen zur verwendung als knochenersatz
EP1389978B1 (de) * 2001-05-01 2009-01-07 Amedica Corporation Röntgendurchlässiges knochentransplantat
US20030039636A1 (en) 2001-05-01 2003-02-27 Genetix Pharmaceuticals, Inc. Novel self-inactivating (SIN) lentiviral vectors
SE519564C2 (sv) 2001-07-04 2003-03-11 Nobel Biocare Ab Implantat, t ex dentalt implantat, belagt med bentillväxtstimulerande medel
SE519566C2 (sv) 2001-07-04 2003-03-11 Nobel Biocare Ab Förfarande för behandling av implantat genom beläggning med kalciumfosfat och bentillväxtstimulerande medel

Also Published As

Publication number Publication date
ES2247423T3 (es) 2006-03-01
DK1448246T3 (da) 2005-12-27
ATE303169T1 (de) 2005-09-15
WO2003043673A1 (en) 2003-05-30
ES2247423T5 (es) 2015-12-30
PT1448246E (pt) 2005-11-30
SI1448246T1 (sl) 2005-12-31
CA2466947A1 (en) 2003-05-30
SI1448246T2 (sl) 2015-12-31
EP1448246A1 (de) 2004-08-25
JP2005509494A (ja) 2005-04-14
US8546334B2 (en) 2013-10-01
EP1448246B2 (de) 2015-09-09
CN1561235A (zh) 2005-01-05
US20150080303A1 (en) 2015-03-19
BR0214275A (pt) 2004-09-21
AU2002308204B2 (en) 2007-09-27
AU2002308204A1 (en) 2003-06-10
US20060088565A1 (en) 2006-04-27
EP1448246B1 (de) 2005-08-31
JP2010075737A (ja) 2010-04-08
CA2466947C (en) 2012-05-22
DK1448246T4 (en) 2015-12-21
CY1105664T1 (el) 2010-12-22
DE60205937D1 (de) 2005-10-06
AU2002308204B9 (en) 2008-06-12
JP5054091B2 (ja) 2012-10-24
DE60205937T3 (de) 2016-01-21
CN100425285C (zh) 2008-10-15
HK1071315A1 (en) 2005-07-15
JP4473576B2 (ja) 2010-06-02

Similar Documents

Publication Publication Date Title
HK1071315A1 (en) Device having osteoinductive and osteoconductive properties
Hing et al. Effect of silicon level on rate, quality and progression of bone healing within silicate-substituted porous hydroxyapatite scaffolds
HUP0401357A2 (hu) Kalcium-foszfát hordozóanyagok csontképződést serkentő fehérjék bejuttatásához
Xiao et al. Hollow hydroxyapatite microspheres: A novel bioactive and osteoconductive carrier for controlled release of bone morphogenetic protein-2 in bone regeneration
Bayani et al. Main properties of nanocrystalline hydroxyapatite as a bone graft material in treatment of periodontal defects. A review of literature
Lyngstadaas et al. Enamel matrix proteins; old molecules for new applications
Hu et al. Cerium-doped whitlockite nanohybrid scaffolds promote new bone regeneration via SMAD signaling pathway
Cabrejos-Azama et al. Magnesium substitution in brushite cements for enhanced bone tissue regeneration
Liu et al. Fluoride incorporation in high phosphate containing bioactive glasses and in vitro osteogenic, angiogenic and antibacterial effects
US20110112654A1 (en) Bone implant application
BRPI0516105B8 (pt) material de implante consistindo em fosfato de cálcio poroso ou colágeno e fosfato de cálcio poroso, material de implante consistindo em aloenxerto ou colágeno e aloenxerto, método de preparação dos mesmos, uso de fosfato de cálcio poroso ou colágeno e fosfato de cálcio poroso na preparação do referido material de implante e uso de aloenxerto ou colágeno e aloenxerto na preparação do referido material de implante
Li et al. Sr-doped nanowire modification of Ca–Si-based coatings for improved osteogenic activities and reduced inflammatory reactions
ATE536855T1 (de) Gewebegerüste zusamensetzungen zur behandlung von zahnerkrankungen
Huang et al. The synergistic effects of Chinese herb and injectable calcium silicate/β-tricalcium phosphate composite on an osteogenic accelerator in vitro
ES2422259T3 (es) Composiciones para la osteogénesis por distracción
Vater et al. Modifications of a calcium phosphate cement with biomolecules—Influence on nanostructure, material, and biological properties
Yu et al. Exogenous VEGF introduced by bioceramic composite materials promotes the restoration of bone defect in rabbits
Al-Hezaimi et al. Efficacy of growth factor in promoting early osseointegration
Kumar et al. Quantitative assessment of degradation, cytocompatibility, and in vivo bone regeneration of silicon-incorporated magnesium phosphate bioceramics
Stanić Boron-containing bioactive glasses for bone regeneration
AU2003251729A1 (en) Use of antibodies against flt-1 for the treatment of osteoporosis
AU2003293870A1 (en) Composite materials made of calcium compounds and polysaccharides containing glucuronic acid and/or iduronic acid
Wang et al. Ascorbate–apatite composite and ascorbate–FGF-2–apatite composite layers formed on external fixation rods and their effects on cell activity in vitro
Komlev et al. Bioactivity and effect of bone formation for octacalcium phosphate ceramics
US9238047B1 (en) Fluorapatite nano-crystalline coated non-ceramic hydrophilic hydroxylapatite bone grafting compositions and methods for promoting bone regeneration

Legal Events

Date Code Title Description
8363 Opposition against the patent